Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen that commonly
causes fatal infections in cystic fibrosis and burn patients as well as in patients who are …

Pseudomonas aeruginosa is an opportunistic pathogen that causes serious infections, is
usually resistant to antimicrobial agents, and is the leading cause of morbidity and …

Pseudomonas aeruginosa remains one of the major pathogens affecting
immunocompromised patients. LPS-based monovalent (MV) and polyvalent (PV) conjugate …

Lipopolysaccharide (LPS) is the major surface antigen of Pseudomonas aeruginosa and
elicits protective antibodies in animals. No cross reaction was observed between LPSs of P …

Pseudomonas aeruginosa is a major cause of respiratory tract infections worldwide,
particularly in hospitalized patients with immunosuppressed conditions and cystic fibrosis …

Pseudomonas aeruginosa is an opportunistic pathogen that localizes to and colonizes
mucosal tissue. Thus, vaccines that elicit a strong mucosal response against P. aeruginosa …

Pseudomonas aeruginosa is a common cause of hospital-acquired infections, including
central line-associated bloodstream infections and ventilator-associated pneumonia …

Pseudomonas aeruginosa is one of the leading causes of nosocomial infections and has
become increasingly resistant to multiple antibiotics. However, development of novel …

Purpose To design and evaluate liposomal constructs capable of inducing a potent systemic
and airway humoral response to Pseudomonas aeruginosa Methods Liposomes contained …

Pseudomonas aeruginosa is an opportunistic pathogen considered a common cause of
nosocomial infection with high morbidity and mortality in burn patients. Immunoprophylaxis …